Thus, modulation of brain cellular cholesterol level by the target genes involving in cellular cholesterol synthesis or trafficking, such as HMGCR, DHCR24, APOE2, and LDLR, could be very valuable for preventing or reversing AD pathology [3, 6, 29, 33, 76, 87]. This evidence concerns the gene LDLR and Alzheimer disease.